Financials Evome Medical Technologies Inc.

Equities

BRTL

CA30053H1055

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 03:27:38 2024-07-12 pm EDT 5-day change 1st Jan Change
0.12 CAD 0.00% Intraday chart for Evome Medical Technologies Inc. +50.00% -42.86%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5.272 5.501 5.506 29.53 24.78 16.46
Enterprise Value (EV) 1 -0.77 -3.803 -2.844 22.45 35.61 40.23
P/E ratio -0.64 x -6.01 x -2.28 x -8 x -1.29 x -0.99 x
Yield 4.81% - - - - -
Capitalization / Revenue -1.91 x 1.78 x -271 x -880 x 0.63 x 0.27 x
EV / Revenue 0.28 x -1.23 x 140 x -669 x 0.9 x 0.67 x
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 0.48 x 0.49 x 0.61 x 3.26 x 1.68 x 4.19 x
Nbr of stocks (in thousands) 33,785 33,785 33,813 46,146 55,063 78,370
Reference price 2 0.1560 0.1628 0.1628 0.6400 0.4500 0.2100
Announcement Date 7/3/18 6/28/19 6/25/20 4/30/21 4/3/23 4/16/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 -2.754 3.085 -0.0203 -0.0335 39.61 59.99
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -7.924 -0.7606 -1.768 -2.667 -22.84 -15.55
Net income 1 -8.06 -0.7606 -2.341 -2.667 -19.08 -15.6
Net margin 292.65% -24.65% 11,517.83% 7,951.3% -48.16% -26.01%
EPS 2 -0.2442 -0.0271 -0.0713 -0.0800 -0.3478 -0.2124
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.007500 - - - - -
Announcement Date 7/3/18 6/28/19 6/25/20 4/30/21 4/3/23 4/16/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 10.8 23.8
Net Cash position 1 6.04 9.3 8.35 7.08 - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) -52.5% -6.42% -17.5% -33.1% -44.2% -161%
ROA (Net income/ Total Assets) -47.1% -6.22% -16.9% -23.3% -15.7% -31.1%
Assets 1 17.12 12.22 13.88 11.43 121.8 50.15
Book Value Per Share 2 0.3300 0.3300 0.2700 0.2000 0.2700 0.0500
Cash Flow per Share 2 0.1800 0.2800 0.2500 0.2100 0.0300 0.0100
Capex 1 0.01 - - - 0.77 0.2
Capex / Sales -0.27% - - - 1.94% 0.34%
Announcement Date 7/3/18 6/28/19 6/25/20 4/30/21 4/3/23 4/16/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.12 CAD
Average target price
2.5 CAD
Spread / Average Target
+1,983.33%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BRTL Stock
  4. Financials Evome Medical Technologies Inc.